Moreover, combining ADAR1i-124 with an epigenetic inhibitor 5-Aza-2′-deoxycytidine (5-Aza-CdR) enhanced its efficacy, particularly in certain cancer cell lines where the expression of ERV dsRNAs and a new ADAR1 dependency were stimulated. Here, ADAR is linked to cancer.